Document is current
Any future updates will be listed below
-
Authors
McGregor, Sophie
Boroditsky, Matthew
Blanchard-Rohner, Geraldine
Loock, Christine
Jade Hildebrand, Kyla https://orcid.org/0000-0003-3825-8202
- License Information
-
More Information
Article History
Received: 24 January 2022
Accepted: 30 May 2022
First Online: 11 June 2022
Declarations
:
: The study protocol was approved by the University of British Columbia’s Women’s and Children’s Research Ethics Board (H20-03309). A waiver of consent was granted because the identifying information was only used to identify eligible patients. Afterwards, each case was assigned a research number with no identifying information.
: Not applicable.
: Dr. Kyla J. Hildebrand is a voting member of the National Advisory Committee on Immunization, a medical director to the Canadian Immunodeficiency Patient Organization, and member of the board of directors for the Canadian Society of Allergy and Clinical Immunology. No other authors have conflicts of interests.
